← Leaderboards
Meghana V Trivedi
Baylor College Of Medicine
$280,151
Attributed
$280,151
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $142.2K · FY2018–19$200K$150K$100K$50K$0
'18
'19
Funding mix
By agency
NIH$280,151 · 2
By mechanism
P20$280,151 · 2
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Suzanne A Fuqua$14,426,929
- Andrew K Groves$21,962,475
- Karen A Niederreither$1,858,277
- Yoshio Yamaoka$2,977,973
- David R Rowley$11,107,276
Others in their field
Other Emerging Leaders on “African American”
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$16,747,735
- Badri N Vardarajan · University Of Miami School Of Medicine$15,302,586
- Michal Engelman · University Of Wisconsin-Madison$12,644,710
- Virginia Kan · George Washington University$9,272,934
- Nicholas David Thomson · Virginia Commonwealth University$9,136,838
- Jorge Eduardo Chavarro · Harvard School Of Public Health$8,571,098
Research focus
African AmericanAnastrozoleAntiandrogen TherapyAnticancer ResearchAntineoplastic AgentsAromatase InhibitorsBaseBindingBreast Cancer CellBreast Cancer Cell LineBreast Cancer PatientCancer EtiologyCancer TherapyCell GrowthCellsCessation Of LifeChemistryChromatinClinically SignificantCollaborationsCollegeComprehensive Cancer CenterDistantAdjuvant
Grant awards (4)
FOXA1 inhibitors to overcome endocrine resistance in ER+ breast cancer$97,522
P20 · FY2019 · CA · contact PI
FOXA1 inhibitors to overcome endocrine resistance in ER+ breast cancer$40,420
P20 · FY2019 · CA · contact PI
FOXA1 inhibitors to overcome endocrine resistance in ER+ breast cancer$100,539
P20 · FY2018 · CA · contact PI
FOXA1 inhibitors to overcome endocrine resistance in ER+ breast cancer$41,670
P20 · FY2018 · CA · contact PI